Scarica l'app Stockscreener
25.36
1.16%
0.29
Dopo l'orario di chiusura:
25.36
Precedente Chiudi:
$25.07
Aprire:
$25.22
Volume 24 ore:
154.36K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.76B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.01%
1M Prestazione:
-6.39%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$24.70
$26.36
Intervallo di 1 settimana:
$23.32
$26.93
Portata 52W:
$18.84
$29.43
Alamar Biosciences Inc Stock (ALMR) Company Profile
Nome
Alamar Biosciences Inc
Settore
Industria
Telefono
510-626-9888
Indirizzo
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
25.36 | 1.69B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Borsa (ALMR) Ultime notizie
Alamar Biosciences Inc. (ALMR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alamar Biosciences, Inc. Revenue Breakdown – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Australia
Alamar Biosciences, Inc. (ALMR) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease - Yahoo Finance
Alamar Biosciences, Inc. (ALMR) Price Book Value - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Alamar Biosciences (NASDAQ: ALMR) adjusts board after director death - Stock Titan
This company just filed for an IPO three months after its parent company went public - The Business Journals
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - The Manila Times
Alamar Biosciences Sets Aug. 10 Results Webcast; Replay to Follow - Stock Titan
IPOs juice biotech real estate (if only a little), but vacancy still climbs and lease rates tumble - The Business Journals
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases - Indovizka.com
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究 - GlobeNewswire Inc.
BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27 - Moomoo
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $30.6, Implies 8% Upside - TradingView
21,000 blood samples to fuel open Alzheimer’s biomarker and AI project - Stock Titan
Alamar Biosciences Launches National-Scale ADRD Proteomics Initiative for Open Biomarker Discovery - Quiver Quantitative
Alamar Biosciences Partners with Leading Research - GlobeNewswire
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - riauone.com
Alamar’s platform to feature in 140+ presentations at AAIC - Investing.com India
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling - Koreabizwire
Alamar Biosciences to Present NULISA Alzheimer’s Data in More Than 140 AAIC Posters and Sessions - Quiver Quantitative
Alamar Biosciences NULISA Data Featured in More Than 140 - GlobeNewswire
Form 13D/A Alamar Biosciences For: 7 July By Investing.com - Investing.com Nigeria
Sands Capital reports 6.1% Alamar Biosciences (ALMR) stake and board change - Stock Titan
Price to book forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - Koreabizwire
Alamar Biosciences Launches First Commercial Blood-Based eMTBR-Tau Assay for Alzheimer’s Disease - Quiver Quantitative
Price to sales forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Sherpa Funds Hold 7.2% of Alamar Biosciences (NASDAQ: ALMR) - Stock Titan
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Index - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Value Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000E Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS:ALMR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Alamar Biosciences Inc (ALMR:UW): Stock Price, Quote and News - BNN Bloomberg
Alamar Biosciences, Inc. (ALMR) Earnings Yield (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P TMI Index - marketscreener.com
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - Koreabizwire
Alamar Biosciences Inc Azioni (ALMR) Dati Finanziari
Non sono disponibili dati finanziari per Alamar Biosciences Inc (ALMR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Alamar Biosciences Inc Azioni (ALMR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):